AbbVie To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga ·  10/30/2023 19:49

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays increased AbbVie Inc. (NYSE:ABBV) price target from $160 to $170. Barclays analyst Carter Gould upgraded the stock from Equal-Weight to Overweight. AbbVie shares fell 4.3% to close at $138.93 on Friday. See how other analysts view this stock.JP Morgan cut the price target for Olin Corporation (NYSE:OLN) from $75 to $48. JP Morgan analyst Jeffrey Zekauskas downgraded the stock from Overweight to Neutral. Olin shares fell 9% to close at $42.12 on Friday

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment